论文部分内容阅读
目的：探讨静脉和口服补铁纠正肾性贫血的临床价值。方法对我院住院部2014年1月~2015年12月收治60例肾性贫血患者的临床治疗资料进行了回顾分析，随机将其分为静脉组和口服组，分别通过静脉注射和口服途径给药，比较分析两组患者临床治疗效果。结果口服组观察对象临床治疗后各项贫血指标结果显著改善，且明显优于静脉组，由此可见，口服途径给药效果明显优于静脉注射给药治疗（P<0.05）。结论肾性贫血患者通过口服途径补铁，且治疗效果较为显著，且明显优于静脉途径给药。“,”Objective To investigate the clinical value of intravenous and oral iron supplementation in the treatment of renal anemia. Methods The author of our hospital inpatient department between January 2015 2014 and December were treated 60 cases of renal anemia in patients with clinical data were retrospectively analyzed randomly divided into vein group and oral group, respectively, by intravenous and oral routes to medicine, compared two groups of patients with clinical treatment effect. Results After clinical treatment, the indexes of anemia were significantly improved, and the effect of intravenous injection was better than that of oral administration (P<0.05). Conclusion Renal anemia patients through intravenous injection of iron, and the treatment effect is more significant, and significantly better than the oral route.